JPH11510370A5 - - Google Patents

Info

Publication number
JPH11510370A5
JPH11510370A5 JP1997501336A JP50133697A JPH11510370A5 JP H11510370 A5 JPH11510370 A5 JP H11510370A5 JP 1997501336 A JP1997501336 A JP 1997501336A JP 50133697 A JP50133697 A JP 50133697A JP H11510370 A5 JPH11510370 A5 JP H11510370A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997501336A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11510370A (ja
Filing date
Publication date
Priority claimed from US08/476,656 external-priority patent/US6251405B1/en
Application filed filed Critical
Publication of JPH11510370A publication Critical patent/JPH11510370A/ja
Publication of JPH11510370A5 publication Critical patent/JPH11510370A5/ja
Ceased legal-status Critical Current

Links

JP9501336A 1995-06-07 1996-06-05 免疫組合せ組成物および方法 Ceased JPH11510370A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/476,656 US6251405B1 (en) 1995-06-07 1995-06-07 Immunological combination compositions and methods
US08/476,656 1995-06-07
US08/588,621 1996-01-19
US08/588,621 US6379675B1 (en) 1995-06-07 1996-01-19 Immunological combination compositions and methods
PCT/US1996/008866 WO1996040290A1 (en) 1995-06-07 1996-06-05 Immunological combination compositions and methods

Publications (2)

Publication Number Publication Date
JPH11510370A JPH11510370A (ja) 1999-09-14
JPH11510370A5 true JPH11510370A5 (https=) 2005-05-26

Family

ID=23892726

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9501336A Ceased JPH11510370A (ja) 1995-06-07 1996-06-05 免疫組合せ組成物および方法

Country Status (12)

Country Link
US (5) US6251405B1 (https=)
EP (1) EP0831937B1 (https=)
JP (1) JPH11510370A (https=)
AT (1) ATE249844T1 (https=)
AU (1) AU717890B2 (https=)
CA (1) CA2223041A1 (https=)
DE (1) DE69630033T2 (https=)
FI (1) FI118591B (https=)
IL (1) IL118579A (https=)
NO (1) NO975620L (https=)
WO (1) WO1996040290A1 (https=)
ZA (1) ZA964894B (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
ZA964896B (en) * 1995-06-07 1997-01-08 Connaught Lab Expression of lipoproteins
CN1255850A (zh) * 1997-05-14 2000-06-07 盖伦(化学制品)有限公司 局部用组合物
WO1999014333A2 (en) * 1997-09-18 1999-03-25 Pasteur Merieux Connaught Improved method of production of pneumococcal surface proteins
WO2000000218A1 (fr) * 1998-06-26 2000-01-06 Aventis Pasteur Immunisation a ciblage mucosal
DE69935606T9 (de) 1998-10-16 2021-03-11 Glaxosmithkline Biologicals S.A. Adjuvanzsysteme und impfstoffe
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2000039302A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AT407958B (de) 1999-02-11 2001-07-25 Immuno Ag Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
DE60014076T2 (de) 1999-04-19 2005-10-13 Glaxosmithkline Biologicals S.A. Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
EP1194559B1 (en) 1999-06-18 2006-09-20 Research Foundation Of State University Of New York Groups of borrelia burgdorferi that cause lyme disease in humans
AU3726001A (en) * 1999-12-09 2001-06-18 Institut Pasteur Systemic immune response induced by mucosal administration of l ipid-tailed polypeptides without adjuvant
US20030232055A1 (en) * 2000-07-31 2003-12-18 Ruslan Medzhitov Innate immune system-directed vaccines
CA2418036A1 (en) * 2000-07-31 2002-02-07 Yale University Innate immune system-directed vaccines
EP1939294A1 (en) 2000-08-18 2008-07-02 Research Foundation Of State University Of New York Recombinant constructs of borrelia burgdorferi
WO2002016421A2 (en) 2000-08-18 2002-02-28 Research Foundation Of The State University Of New York Altered ospa of borrelia burgdorferi
US20030175287A1 (en) * 2001-01-03 2003-09-18 Yale University Innate immune system-directed vaccines
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
US20080299140A1 (en) * 2002-05-24 2008-12-04 The Regents Of The University Of California, Immunogenic Composition and Peptide Sequences for Prevention and Treatment of an Hsv Condition
FR2846004B1 (fr) * 2002-10-16 2006-06-23 Maco Pharma Sa Composition pour culture de cellules notamment animales ou de tissus, comprenant du polyethylene glycol
WO2005115430A1 (en) * 2004-05-27 2005-12-08 Gropep Limited Treatment of inflammatory airway disease
US8029777B2 (en) * 2004-08-13 2011-10-04 Marshall Barry J Helicobacter system and uses thereof
WO2006015445A1 (en) 2004-08-13 2006-02-16 Marshall Barry J Bacterial delivery system
US20070224205A1 (en) 2006-03-07 2007-09-27 Powell Thomas J Compositions that include hemagglutinin, methods of making and methods of use thereof
RU2348406C1 (ru) * 2007-05-02 2009-03-10 Федеральное Государственное Учреждение НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИУТ ДЕТСКИХ ИНФЕКЦИЙ Способ лечения бактериальных гнойных менингитов у детей
US8426163B2 (en) * 2007-12-07 2013-04-23 National Health Research Institutes Production of lipidated proteins in E. coli
US8466259B2 (en) * 2007-12-07 2013-06-18 National Health Research Institutes Adjuvants
EP2274616A1 (en) 2008-04-22 2011-01-19 The Research Foundation of State University of New York Borrelia burgdorferi cell envelope protein array
US8287880B2 (en) 2009-06-02 2012-10-16 National Health Research Institutes Lipidated vaccine against dengue virus infection
US8658176B2 (en) * 2009-06-22 2014-02-25 National Health Research Institutes Lipidated tumor-associated antigens and immunotherapeutic compositions
CN102695523A (zh) * 2009-09-10 2012-09-26 诺华有限公司 针对呼吸道疾病的组合疫苗
TW201221642A (en) 2010-11-15 2012-06-01 Nat Health Research Institutes Method of producing lipidated polypeptides
TWI507413B (zh) 2010-11-15 2015-11-11 Nat Health Research Institutes 脂質化多抗原表位疫苗
ES2615230T3 (es) 2010-12-29 2017-06-06 Oceanspar, Inc Corral para peces con pértiga central y método para retener un pez en aguas abiertas
US9943583B2 (en) * 2013-12-03 2018-04-17 Universität Zürich Proline-rich peptides protective against S. pneumoniae
HK1244534A1 (zh) 2014-10-07 2018-08-10 The Research Foundation For The State University Of New York 重组疏螺旋体蛋白及其使用方法
WO2025015077A1 (en) * 2023-07-10 2025-01-16 Dynavax Technologies Corporation Lyme disease vaccines comprising an adjuvant and borrelia outer surface protein a and c antigens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4302386A (en) * 1978-08-25 1981-11-24 The Ohio State University Antigenic modification of polypeptides
EP0014815A3 (de) 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
US4258029A (en) 1979-04-23 1981-03-24 Connaught Laboratories Limited Synthetic adjuvants for stimulation of antigenic responses
US4455142A (en) 1980-07-07 1984-06-19 Alza Corporation Method of coadministering an antigen and an immunopotentiator
US4484923A (en) * 1982-03-25 1984-11-27 Alza Corporation Method for administering immunopotentiator
DE3521994A1 (de) 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4839293A (en) * 1986-02-24 1989-06-13 The Trustees Of Columbia University In The City Of New York DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
EP0270295A3 (en) * 1986-12-03 1989-08-02 Connaught Laboratories Limited Conjugate vaccine
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US5098997A (en) * 1987-12-11 1992-03-24 Praxis Biologics, Inc. Vaccines for Haemophilus influenzae
WO1990003441A1 (en) 1988-09-20 1990-04-05 Marvin Murray Accelerated microdilution determination of bacteria susceptibility to antibiotics
AU7058691A (en) 1989-12-22 1991-07-24 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine
CA2032914A1 (en) * 1989-12-26 1991-06-27 Peter C.K. Lau Use of bacterial lipoprotein amino terminus in fusion plasmids for in vivo expression of lipid modified polypeptides
DK0571538T5 (da) 1991-02-15 2002-03-04 Uab Research Foundation Strukturgen for pneumokokprotein
JPH07501687A (ja) * 1991-08-15 1995-02-23 スミスクライン・ビーチャム・バイオロジカルス（ソシエテ・アノニム） ボレリア・ブルグドルフェリのサブグループのｏｓｐ　ａ　蛋白、それをコードしている遺伝子およびワクチン
WO1993007897A1 (en) * 1991-10-21 1993-04-29 Medimmune, Inc. Bacterial expression vectors containing dna encoding secretion signals of lipoproteins
AU2903892A (en) * 1991-10-22 1993-05-21 Symbicom Aktiebolag Improvement in (borrelia burgdorferi) diagnosis and prophylaxis
CA2105629A1 (en) * 1992-09-14 1994-03-15 Robert S. Becker Potentiation of immunogenic response
WO1994014318A1 (en) * 1992-12-24 1994-07-07 Medimmune, Inc. Method of protection against streptococcus pneumoniae with transformed mycobacteria
FR2708622B1 (fr) * 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.

Similar Documents

Publication Publication Date Title
JP2000500445A5 (https=)
JP2000500228A5 (https=)
JP2000500440A5 (https=)
JP2000500327A5 (https=)
JP2000500145A5 (https=)
JP2000500155A5 (https=)
JP2000500406A5 (https=)
JP2000502263A5 (https=)
JP2000500361A5 (https=)
JP2000500115A5 (https=)
JPH11512123A5 (https=)
JP2000500322A5 (https=)
JP2000500258A5 (https=)
JP2000500342A5 (https=)
JP2000500192A5 (https=)
JP2000500112A5 (https=)
JP2000509095A5 (https=)
JP2000500226A5 (https=)
JPH11510370A5 (https=)
JP2000500407A5 (https=)
JP2000500397A5 (https=)
JP2000500166A5 (https=)
JP2000500125A5 (https=)
JP2001500068A5 (https=)
JP2000500346A5 (https=)